A patient in a small mRNA vaccine trial shows no evidence of pancreatic cancer that was previously considered terminal, marking a significant early result.
An artificial intelligence framework named REDMOD can identify subtle signs of pancreatic cancer up to three years before clinical diagnosis, potentially transforming early detection strategies.
NYU Langone scientists used single-cell analysis to show how pancreatic cancer rewrites its DNA to resist treatment and spread. Blocking the MYC gene reversed aggression.
